This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mead, P. Articles by Thomas, T. H. Search for Related Content PubMed PubMed Citation Articles by Mead, P. Articles by Thomas, T. H.

(Hypertension. 1999;34:1275.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Thiol Protein Defect in Sodium-Lithium Countertransport in Subset of Essential Hypertension

Paul Mead; Robert Wilkinson; Trevor H. Thomas

From the Department of Medicine (Nephrology), University of Newcastle-on-Tyne, Newcastle-on-Tyne, UK.

Correspondence to Dr T.H. Thomas, Department of Medicine, Medical School, University of Newcastle-on-Tyne, Framlington Place, Newcastle-on-Tyne, NE2 4HH, UK. E-mail T.H.Thomas{at}ncl.ac.uk

Abstract—There is probably a heterogeneous etiology for essential hypertension (EHT), and abnormal erythrocyte sodium-lithium countertransport (Na/Li CT) is common in a subgroup of patients with a strong family history of hypertension and cardiovascular disease (EHT-FH patients). The aim of this study was to test the hypothesis that altering a membrane thiol protein could mimic the abnormal Na/Li CT observed in the patients and that a more refined understanding of the mechanism of abnormal Na/Li CT would facilitate a clearer identification of a subgroup of patients with a homogeneous biochemical abnormality. Na/Li CT kinetics were determined in untreated erythrocytes and after thiol group alkylation with N-ethylmaleimide (NEM). Compared with normal control erythrocytes, untreated erythrocytes from EHT-FH patients had a low K_m of Na/Li CT, with a high ratio of maximum velocity to K_m. This kinetic pattern was reproduced in normal erythrocytes by treatment with NEM in sodium-free medium. The same treatment in EHT-FH erythrocytes caused a markedly abnormal effect with an increase in maximum velocity, indicating an increase in transporter turnover in contrast to the increase in sodium affinity seen in normal control erythrocytes. Frequency distributions of these kinetic changes showed a subgroup of 75% of EHT-FH patients with abnormal kinetic changes with NEM. Therefore, the key Na/Li CT thiol group that is very reactive to NEM and causes the abnormal Na/Li CT in a subgroup of hypertensive patients may be a useful intermediate phenotype for a disease group within the syndrome of EHT. The single flux assay of Na/Li CT at 140 mmol/L sodium poorly discriminates this group. Identification of the thiol protein involved may lead to a molecular explanation of the altered membrane function in this subgroup of patients.

Key Words: erythrocytes • hypertension, essential • kinetics • sodium-lithium countertransport

This article has been cited by other articles:

				O. Vaccaro, V. Cuomo, M. Trevisan, M. Cirillo, W. Panarelli, M. Laurenzi, M. Mancini, G. Riccardi, and On behalf of the Gubbio Study Research Group Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes Int. J. Epidemiol., October 1, 2005; 34(5): 1123 - 1128. [Abstract] [Full Text] [PDF]

				S. A. Dunn, M. Mohteshamzadeh, A. K. Daly, and T. H. Thomas Altered Tropomyosin Expression in Essential Hypertension Hypertension, February 1, 2003; 41(2): 347 - 354. [Abstract] [Full Text] [PDF]

				N. J. Schork, J. P. Gardner, L. Zhang, D. Fallin, B. Thiel, H. Jakubowski, and A. Aviv Genomic Association/Linkage of Sodium Lithium Countertransport in CEPH Pedigrees Hypertension, November 1, 2002; 40(5): 619 - 628. [Abstract] [Full Text] [PDF]

				P. A. Mead, R. Wilkinson, and T. H. Thomas Na/Li Countertransport Abnormalities in Type 1 Diabetes With and Without Nephropathy Are Familial Diabetes Care, March 1, 2001; 24(3): 527 - 532. [Abstract] [Full Text]